FIELD: monosubstituted or disubstituted potassium salts.
SUBSTANCE: invention relates to a monosubstituted or disubstituted potassium salt of the HAEE peptide, where HAEE is a synthetic peptide, acetylated at the N-terminus and amidated at the C-terminus, with the amino acid sequence His-Ala-Glu-Glu. The present invention also relates to a method for producing potassium salts of the HAEE peptide (options), to pharmaceutical compositions based on potassium salts of the HAEE peptide and the use of potassium salts of the HAEE peptide for the treatment of neurodegenerative diseases.
EFFECT: creation of HAEE peptide for the treatment of neurodegenerative diseases.
36 cl, 11 dwg, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMMONIUM SALT OF HAEE PEPTIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784249C1 |
| SODIUM SALT OF HAEE PEPTIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784326C1 |
| HAEE PEPTIDE MAGNESIUM COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784746C1 |
| HAEE PEPTIDE COPPER COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784732C1 |
| PEPTIDE CALCIUM COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2785354C1 |
| HAEE PEPTIDE ZINC COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784319C1 |
| HAEE SYNTHETIC TETRAPEPTIDE AND DERIVATIVES THEREOF INTENDED FOR HUMAN NEURON FUNCTION RECOVERY | 2023 |
|
RU2822603C1 |
| SYNTHETIC TETRAPEPTIDE HAEE AND DERIVATIVES THEREOF INTENDED FOR PROTECTION OF HUMAN NEURON FUNCTION | 2023 |
|
RU2822602C1 |
| METHOD FOR TREATING NEURODEGENERATIVE DISEASES | 2021 |
|
RU2777871C1 |
| PHARMACEUTICAL COMPOSITION BASED ON HAEE PEPTIDE FOR TREATING NEURODEGENERATIVE DISEASES | 2019 |
|
RU2709539C1 |
